Description
DECREASE FUNDING BY $290,490.02 FOR TESTING MOLECULAR ANALYZER/REAGENTS NOT RECEIVED.
Base award description: OPT 1 DO - ADMINISTRATIVE CORRECTION TO COVID 19 TESTING /MOLECULAR ANALYZER/REAGENTS - HIGH VOLUME OUTPUT ANALYZER WITHOUT THE NEED TO ALIQUOT - ADD PRODUCTS TO ATTACHMENT A
Modification chain · 4 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2021-10-14+$2,154,829= $2,154,829
- Mod P000012023-06-07-$297,361= $1,857,468
- Mod P000022023-06-09-$290,490= $1,566,978
- Mod P000032024-04-22+$4,850= $1,571,828
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2021-10-14 | +$2,154,829 | $2,154,829 | OPT 1 DO - ADMINISTRATIVE CORRECTION TO COVID 19 TESTING /MOLECULAR ANALYZER/REAGENTS - HIGH VOLUME OUTPUT ANA… |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2023-06-07 | −$297,361 | $1,857,468 | DE-OBLIGATE $297,360.60 FOR COVID 19 TESTING /MOLECULAR ANALYZER/REAGENTS NOT RECEIVED DURING POP: 10/15/2021… |
| Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2023-06-09 | −$290,490 | $1,566,978 | DECREASE FUNDING BY $290,490.02 FOR TESTING MOLECULAR ANALYZER/REAGENTS NOT RECEIVED. |
| Mod P00003· FUNDING ONLY ACTION | 2024-04-22 | +$4,850 | $1,571,828 | DECREASE FUNDING BY $290,490.02 FOR TESTING MOLECULAR ANALYZER/REAGENTS NOT RECEIVED. |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI NK5QDVJBHMN7)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24126N0799 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $658,750 | FY2026 |
| 36C26326P0588 | NETWORK CONTRACT OFFICE 23 (36C263) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $308,299 | FY2026 |
| 36C24126A0041 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $0 | FY2026 |
| 36C24226N0439 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $1,481,077 | FY2026 |
| 36C24926N0423 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $471,122 | FY2026 |
| 36C24626N0476 | 246-NETWORK CONTRACTING OFFICE 6 (36C246) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $421,178 | FY2026 |
Other recipients under 6640 from 255-NETWORK CONTRACT OFFICE 15 (36C255) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25526A0038 | SIEMENS HEALTHCARE DIAGNOSTICS INC. | 255-NETWORK CONTRACT OFFICE 15 (36C255) | $0 | FY2026 |
| 36C25526N0419 | SIEMENS HEALTHCARE DIAGNOSTICS INC. | 255-NETWORK CONTRACT OFFICE 15 (36C255) | $206,949 | FY2026 |
| 36C25526N0374 | ABBOTT LABORATORIES INC. | 255-NETWORK CONTRACT OFFICE 15 (36C255) | $881,319 | FY2026 |
| 36C25526N0387 | ABBOTT LABORATORIES INC. | 255-NETWORK CONTRACT OFFICE 15 (36C255) | $165,764 | FY2026 |
| 36C25526N0379 | WERFEN USA LLC | 255-NETWORK CONTRACT OFFICE 15 (36C255) | $671,956 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25522N0027_3600_36C25521A0001_3600 · retrieved 2026-09-26.